SCHEMBL28448356

SCHEMBL28448356

Oc1nocc1C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 2/20 0.39
S1PR3 Q99500 5/20 0.35
CEL P19835 2/20 0.33
NUDT1 P36639 1/20 0.33
BACE1 P56817 1/20 0.33
HSP90AA1 P07900 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
CNR1 P21554 5/20 0.33
CNR2 P34972 5/20 0.33
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
S1PR1 P21453 2/20 0.32
FEN1 P39748 1/20 0.31
POLB P06746 1/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28742447 0.94 TDO2 (0.33) TDO2S1PR3FEN1
SCHEMBL23137845 0.73 TDO2 (0.37) TDO2S1PR3CELKDM4ES1PR1
SCHEMBL8703975 0.72 CNR1 (0.34) TDO2S1PR3NUDT1BACE1HSP90AA1
SCHEMBL23137848 0.71 TDO2 (0.35) TDO2S1PR3CELKDM4ES1PR1
SCHEMBL30436490 0.71 KDM4E (0.40) TDO2S1PR3CELKDM4EMEN1
SCHEMBL28565231 0.68 HCAR2 (0.37) TDO2S1PR3KDM4EKMT2A
SCHEMBL23293575 0.68 PTGDR2 (0.34) TDO2S1PR3
SCHEMBL30437079 0.67 KDM4E (0.36) TDO2S1PR3KDM4EMEN1MAPT
SCHEMBL7760634 0.64 NUDT1 (0.52) TDO2CELNUDT1BACE1HSP90AA1
SCHEMBL28485353 0.64 PTGDR2 (0.36) TDO2NUDT1BACE1HSP90AA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074515-A Cyclohexyl acid isoxazoles as LPA antagonists 百时美施贵宝公司 2020-12-11 CN disclosed
CN-111479807-A Cyclohexyl acid isoxazoles azines as L PA antagonists 百时美施贵宝公司 2020-07-31 CN disclosed